Stock Research: Carl Zeiss Meditec

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Carl Zeiss Meditec

GER:AFX DE0005313704
62
  • Value
    93
  • Growth
    14
  • Safety
    Safety
    94
  • Combined
    90
  • Sentiment
    10
  • 360° View
    360° View
    62
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Carl Zeiss Meditec AG is a medical technology and device company offering solutions for diagnosing and treating ophthalmic diseases. It operates in the medical technology industry, specifically in ophthalmic devices and microsurgery. The company operates in Germany and offers support services. In the last fiscal year, the company had a market cap of $5,249 million, profits of $1,212 million, and revenue of $2,300 million, with 5,730 employees.

more
Index
CDAX
MDAX
TecDAX
Sound Pay Europe
Renewables Users
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
93 72 43 31
Growth
14 12 53 57
Safety
Safety
94 79 86 90
Sentiment
10 1 3 70
360° View
360° View
62 22 45 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
7 19 12 19
Opinions Change
6 15 10 56
Pro Holdings
n/a 8 26 86
Market Pulse
61 25 38 62
Sentiment
10 1 3 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
93 72 43 31
Growth
14 12 53 57
Safety Safety
94 79 86 90
Combined
90 64 82 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
82 61 42 22
Price vs. Earnings (P/E)
71 39 32 19
Price vs. Book (P/B)
85 70 29 36
Dividend Yield
60 54 55 45
Value
93 72 43 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
40 57 63 45
Profit Growth
41 8 26 17
Capital Growth
36 66 81 81
Stock Returns
1 4 31 67
Growth
14 12 53 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
75 62 80 82
Refinancing
90 63 63 53
Liquidity
61 55 67 77
Safety Safety
94 79 86 90

Similar Stocks

Discover high‑ranked alternatives to Carl Zeiss Meditec and broaden your portfolio horizons.

KSB

GER:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

ALSO

SWX:ALSN
Country: Germany
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

TAG Immobilien

GER:TEG
Country: Germany
Industry: Real Estate: Operating Services
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: